Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

67%(2 trials)

Phase Distribution

Ph phase_1

40%

Ph phase_2

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

2(40.0%)

Phase 2Efficacy & side effects

3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Other(1)

Detailed Status

Completed3

unknown1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 12 (40.0%)

Phase 23 (60.0%)

Trials by Status

unknown120%

completed360%

not_yet_recruiting120%

Recent Activity

0 active trials

Showing 5 of 5

not_yet_recruitingphase_2

Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons

NCT05382091

completedphase_1

The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

NCT03810495

unknownphase_1

Clinical Trials (5)

Showing 5 of 5 trials

NCT05382091Phase 2

Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons

Not Yet Recruiting

NCT03810495Phase 1

The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

Completed

NCT05919017Phase 1

Exploring the PK of Different Doses of Naltrexone in Patients With AUD

Unknown

NCT00218426Phase 2

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

Completed

NCT01101815Phase 2

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5